ADVANCE: Risk of Cardiovascular Disease and Diabetes in Treatment-Naive Patients Initiating Dolutegravir- or Efavirenz-Based ART

Expert selections of important HIV data from AIDS 2022, including current and investigational strategies for prevention, ART, comorbidities, and cure

Joseph J. Eron, Jr., MD Jeffrey Kwong, DNP, MPH, FAANP, FAAN Milena Murray, PharmD, MSc, BCIDP, AAHIVP, FCCP David A. Wohl, MD Released: September 23, 2022

Expert selections of important HIV data from AIDS 2022, including current and investigational strategies for prevention, ART, and comorbidities

Jeffrey Kwong, DNP, MPH, FAANP, FAAN Released: September 23, 2022

Clinical Care Options (CCO) expert analysis of new data from AIDS 2022, provided by expert HIV faculty

Chloe Orkin, MBChB, FRCP, MD Released: September 20, 2022

Expert perspective on reports from AIDS 2022 that may impact treatment of people with HIV in the Asia-Pacific region, from Clinical Care Options (CCO)

Chien-Ching Hung, MD, PhD Released: September 16, 2022